Drug Discovery and Design B
PHAR2821
This unit of study covers drug design; physicochemical properties of drugs and how this determines the interactions of small molecules (drugs) with biological macromolecules (enzymes and receptors). All stages in the process of drug design and development will be investigated, including computational drug design and the required mathematics for computation and statistical treatment; role of stereochemistry in drug action, structure-activity relationships and molecular modelling; drug metabolism, bioactivation and inactivation; advanced analytical methods for the identification of drugs, their metabolites and degradation products; sources of drugs; discovery of new small molecules as leads for drug development. Workshops consist of the Stereochemistry/Ligand-Based Drug Design molecular modelling workshop, drug action workshop and drug metabolism problem-based learning workshop.
Unit of study details
Unit of study level: Intermediate
Credit points: 6
Commencing semesters: 2
Further unit of study information
Unit of study handbook: PHAR2821
Costs and scholarships information: Costs and Scholarships
Final dates to withdraw from units of study: Census Dates
Available for study abroad and exchange: Yes